Pfizer Inc., the drug and hospital products giant, suggested yesterday that Wall Street's earnings projections of $4.25 a share for the 1994 fiscal year were "somewhat optimistic." That assessment, which was delivered at an analysts' meeting in New York by Pfizer's chief financial officer, Henry McKinnell, sent the stock tumbling.
